Gene · 4855
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Migratory allylic arylation of 1,n-enols enabled by nickel catalysis. | Nat Commun | 2023 | 37286547 | PubTator, text mining | PubMed |
| Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma. | Front Genet | 2023 | 37284062 | PubTator, text mining | PubMed |
| Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer. | Epigenetics | 2023 | 37279148 | PubTator, text mining | PubMed |
| Insufficient GDF15 expression predisposes women to unexplained recurrent pregnancy loss by impairing extravillous trophoblast invasion. | Cell Prolif | 2023 | 37272232 | PubTator, text mining | PubMed |
| Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective. | J Mammary Gland Biol Neoplasia | 2023 | 37269418 | PubTator, text mining | PubMed |
| NOTCH4ΔL12_16 sensitizes lung adenocarcinomas to EGFR-TKIs through transcriptional down-regulation of HES1. | Nat Commun | 2023 | 37268635 | PubTator, text mining | PubMed |
| To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations. | J Cancer Res Clin Oncol | 2023 | 37261523 | PubTator, text mining | PubMed |
| Editorial: The notch signaling pathway in lymphoid malignancies. | Front Oncol | 2023 | 37260980 | PubTator, text mining | PubMed |
| SOX18-enforced expression diverts hemogenic endothelium-derived progenitors from T towards NK lymphoid pathways. | iScience | 2023 | 37250328 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of Glutathione Peroxidase 1 (Gpx-1) as an Independent Prognostic Factor in Colon Adenocarcinoma Patients. | Pharmaceuticals (Basel) | 2023 | 37242524 | PubTator, text mining | PubMed |
| NOTCH1 Gene as a Novel Cause of Thoracic Aortic Aneurysm in Patients with Tricuspid Aortic Valve: Two Cases Reported. | Int J Mol Sci | 2023 | 37239988 | PubTator, text mining | PubMed |
| Decoding the Human Epidermal Complexity at Single-Cell Resolution. | Int J Mol Sci | 2023 | 37239891 | PubTator, text mining | PubMed |
| Emerging Intrinsic Therapeutic Targets for Metastatic Breast Cancer. | Biology (Basel) | 2023 | 37237509 | PubTator, text mining | PubMed |
| Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation. | Sci Adv | 2023 | 37235659 | PubTator, text mining | PubMed |
| TMEM16A/F support exocytosis but do not inhibit Notch-mediated goblet cell metaplasia of BCi-NS1.1 human airway epithelium. | Front Physiol | 2023 | 37234411 | PubTator, text mining | PubMed |
| Common Signaling Pathways Involved in Alzheimer's Disease and Stroke: Two Faces of the Same Coin. | J Alzheimers Dis Rep | 2023 | 37220617 | PubTator, text mining | PubMed |
| GS-SMD server for steered molecular dynamics of peptide substrates in the active site of the γ-secretase complex. | Nucleic Acids Res | 2023 | 37207343 | PubTator, text mining | PubMed |
| Disease tolerance: a protective mechanism of lung infections. | Front Cell Infect Microbiol | 2023 | 37207185 | PubTator, text mining | PubMed |
| Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment. | Front Pharmacol | 2023 | 37205904 | PubTator, text mining | PubMed |
| Inhibition of the intracellular domain of Notch1 results in vascular endothelial cell dysfunction in sepsis. | Front Immunol | 2023 | 37205094 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4855/papers?page=18